Has Angelo Paredes, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,303,068 in general payments to Angelo Paredes, MD across 679 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Angelo Paredes, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Angelo Paredes, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Angelo Paredes, MD

Gastroenterology · Middletown, CTNPI 1235289398

Payments from drug & device makers

$1,303,068in general payments, 2019–2025

Across 679 payments — averaging $1919.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intercept Pharmaceuticals, Inc.$943K
AbbVie$210K
Intercept Pharma Europe Ltd.$81K
Bristol Myers Squibb$44K
Echosens North America, Inc.$6K
Madrigal Pharmaceuticals$5K
plus $13K from 30 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intercept Pharmaceuticals, Inc.	94	$942,830
AbbVie(2 entities)	125	$209,956
Intercept Pharma Europe Ltd.	8	$81,311
Bristol Myers Squibb	53	$44,227
Echosens North America, Inc.	9	$6,300
Madrigal Pharmaceuticals	15	$4,990
E.r. Squibb & Sons, L.L.C.	2	$4,544
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	101	$1,918
Gilead	41	$1,533
Takeda Pharmaceuticals U.S.A., Inc.	53	$1,301
Ardelyx, Inc.	27	$591
Johnson & Johnson(2 entities)	25	$515
QOL Medical, LLC	18	$457
Regeneron Healthcare Solutions, Inc.	11	$234
Pfizer	12	$230
Redhill Biopharma Inc.	10	$180
Aimmune Therapeutics, Inc.	6	$172
Ironwood Pharmaceuticals, Inc	8	$170
Sanofi	7	$168
Mallinckrodt Hospital Products Inc.	2	$157
Organon	7	$138
Braintree Laboratories, Inc.	7	$130
Nestle Healthcare Nutrition Inc.	7	$124
Dova Pharmaceuticals	1	$123
Medtronic	1	$104
Ferring Pharmaceuticals Inc.	7	$102
Phathom Pharmaceuticals, Inc.	5	$85
Pentax Of America, Inc.	1	$82
Boston Scientific	1	$76
Lilly USA, LLC	4	$73
Celltrion USA Inc.	2	$51
Amgen	2	$48
Exact Sciences	2	$42
Novo Nordisk	2	$42
Lucid Diagnostics Inc.	2	$39
Mirum Pharmaceuticals, Inc.	1	$23

How this compares

$1,303,068 in reported general payments places this provider in the 95th percentile of 326 gastroenterology providers in Connecticut.

See all gastroenterology providers in Connecticut →

Medicare billing

Part B allowed, 2024

$94,230

Medicare patients

258

Services billed

1,826

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Middletown

Mario RicciMiddletown$121K
Pramod MistryNew Haven$6M
Salam ZakkoBristol$2.7M
Paul FeuerstadtHamden$1.4M
James FrestonFarmington$778K
Jill GaidosNew Haven$750K
Houman RezaizadehFarmington$720K
James BoyerNew Haven$648K
Guadalupe Garcia TsaoNew Haven$555K
Loren LaineWest Haven$485K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →